Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AXSOME THERAPEUTICS, INC.”

127 pharma patents match "AXSOME THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 127
Index total 30,257
Page 4 / 6

Quick answer

This filtered view shows 127 pharmaceutical patents matching "AXSOME THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

127 results for “AXSOME THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 10987358

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  2. US 10940153

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  3. US 10933136

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  4. US 10933137

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  5. US 10918722

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted

  6. US 10905693

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  7. US 10894053

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  8. US 10821181

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  9. US 10821182

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  10. US 10799588

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  11. US 10780166

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  12. US 10780165

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  13. US 10758617

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  14. US 10758618

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  15. US 10729774

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  16. US 10729696

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  17. US 10729773

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  18. US 10729697

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  19. US 10722583

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  20. US 10702535

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  21. US 10702602

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  22. US 10695429

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  23. US 10695304

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  24. US 10695430

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.